# ACM Research Inc. (ACMR) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Technology / Semiconductors & Semiconductor Equipment. Price $74.44, market value $5.2 billion.

## Valuation
- **P/E (trailing): 35.1×** (5-yr avg 23.5×, 3-yr avg 18.5×). ACM Research Inc. trades at 35.1× trailing earnings, well above its own five-year average of 23.5×: investors are paying up relative to the company's past. The Technology median in the September 2026 study was 32.1×. Forward P/E is 25.7×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 5.0×**. Each dollar of revenue is priced at 5.0×.
- **Price / book: 2.8×**. The shares trade at 2.8× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 29.3×**. Enterprise value is 29.3× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: -2.3%** (5-yr avg -7.9%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.
- **Earnings yield: 2.8%**. The inverse of the P/E: 2.8% of the price is earned each year.

## Profitability
- **Gross margin: 43.8%**. ACM Research Inc. keeps 43.8% of revenue after the direct cost of what it sells.
- **Operating margin: 13.3%**. 13.3% of revenue is left after running the business.
- **Net margin: 10.4%**. 10.4% of each dollar of sales reaches the bottom line.
- **Return on equity: 6.4%**. 6.4% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 11.8%**. Return on all capital, debt included, is 11.8%.
- **Return on assets: 5.2%**. Each dollar of assets produces 5.2% of profit.

## Growth
- **Revenue growth (1 yr): 15.2%** (3-yr 32.3%/yr, 5-yr 41.9%/yr). Revenue grew 15.2% over the last year, against 41.9% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -10.5%** (3-yr 32.4%/yr, 5-yr 35.5%/yr). Earnings per share fell 10.5%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 0.15**. Debt is 0.15 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. ACM Research Inc. holds more cash than debt.
- **Altman Z-score: 4.46**. A Z-score of 4.46 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 1/9**. 1 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. ACM Research Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (8 analysts). 8 analysts cover ACM Research Inc.; the consensus is strong_buy, with an average price target of $117.75 (+58% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 175.9%** (YTD 88.7%, 3-mo -2.4%). The shares are up 175.9% over twelve months including dividends.
- **From 52-week high: -41.5%** (181.5% above the low). Trading 41% below its 52-week high, deep in a drawdown.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 45**. An RSI of 45 is neutral.
- **Beta (1 yr): 3.68** (volatility 87%). Beta of 3.68 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ACMR · Page: https://foliofundamentals.com/stocks/acmr

Not investment advice.